Related Experiment Video
Updated: Jul 30, 2025
11:31
High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
Published on: August 16, 2019
8.0K
Advanced Delivery Strategies for Immunotherapy in Type I Diabetes Mellitus
Mingshu Huang1, Weixing Chen1, Min Wang1
1Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, China.
Summary
Type 1 diabetes (T1DM) is an autoimmune disease. Advanced drug delivery enhances immunotherapy effectiveness and reduces side effects for T1DM treatment.
Area of Science:
- Immunology
- Endocrinology
- Biomedical Engineering
Background:
- Type 1 diabetes mellitus (T1DM) is an autoimmune condition causing pancreatic beta cell destruction and insulin deficiency.
- Current T1DM immunotherapy research focuses on T-cell-mediated beta cell destruction, facing challenges like low response rates and sustained efficacy.
- Advanced drug delivery systems offer potential to improve immunotherapy potency and minimize adverse effects in T1DM management.
Purpose of the Study:
- To review the mechanisms of T1DM immunotherapy.
- To summarize the integration of advanced drug delivery techniques with T1DM immunotherapy.
- To analyze current challenges and future prospects in T1DM immunotherapy.
Main Methods:
- Literature review of T1DM immunotherapy mechanisms.
- Analysis of current research on drug delivery strategies for T1DM immunotherapy.
- Critical evaluation of challenges and future directions in the field.
Main Results:
- Immunotherapy aims to rescue T-cell-mediated beta cell destruction in T1DM.
- Advanced drug delivery can enhance immunotherapy efficacy and reduce side effects.
- Key challenges include response rates and maintaining therapeutic effects.
Conclusions:
- Integration of advanced drug delivery is crucial for optimizing T1DM immunotherapy.
- Further research is needed to overcome existing challenges and advance T1DM treatment.
- Future directions involve refining delivery techniques for improved T1DM management.
Related Concept Videos
01:27Insulin Formulations: Types and Delivery
240
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
240
01:27Tumor Immunotherapy
587
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
587
01:16Insulin: Dosing Regimen and Adverse Effects
217
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
217
01:22Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
01:15Diabetes: Management and Pharmacotherapy
319
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319
01:40Cell-mediated Immune Responses
69.2K
Overview
69.2K